Delivery Order SPE2DR25D3103-SPE2DR26F9S87
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,559.84 on December 4, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) under a firm fixed-price contract. The award was made on a competitive basis with no set-aside designation. Performance will be executed from the company's Conshohocken, Pennsylvania location, with an ultimate completion date of December 26, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp for Ibrance 125 mg capsules (quantity 21) on December 20, 2025, with completion targeted for January 13, 2026. This is a firm fixed-price, non-competitive set-aside delivery order issued to the prime contractor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as...
- The Defense Logistics Agency awarded a delivery order valued at $24,367.44 to AmerisourceBergen Drug Corp for the supply of Ibrance 100 mg capsules (21-count package) on August 27, 2025, with an ultimate completion date of September 18, 2025. This competitive award uses firm fixed pricing and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in that...
- The Defense Logistics Agency awarded a $8,559.84 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Ibrance 100 mg capsules (21-count). This competitive, non-set-aside contract represents a firm fixed price delivery order with an ultimate completion date of January 8, 2026, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child contract issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $8,555.21 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Ibrance 125 mg capsules (21-count packages). This is a firm fixed price, competitively awarded contract with no set-aside designation and a completion date of December 30, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,559.84 on December 23, 2025, for the supply of Ibrance 100 mg tablets (7-count packaging). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of January 15, 2026. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,122.82 to AmerisourceBergen Drug Corp for the supply of Ibrance 75 mg capsules (21-count units). This firm fixed-price delivery order, issued on November 18, 2025, with completion targeted for December 10, 2025, represents a non-competitive set-aside award supporting federal pharmaceutical procurement needs. The product will be supplied from the vendor's location in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Ibrance 125 mg capsules (21-count units) with a contract ceiling value of $8,555.21. This is a firm fixed-price delivery order with an ultimate completion date of January 2, 2026, representing a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The award was competitively made with no set-aside designation, and...
- The Defense Logistics Agency awarded a delivery order valued at $8,559.84 to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count). This is a firm fixed-price delivery order with an ultimate completion date of January 21, 2026, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $8,118.09 to AmerisourceBergen Drug Corp for 21 capsules of Ibrance 125 mg on October 28, 2025, with completion expected by November 19, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The pharmaceutical product will be supplied from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9S87Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Ibrance 100 mg capsules (21-count packages) with a ceiling value of $8,559.84. This firm fixed-price delivery order represents a non-competitive set-aside award and is scheduled for completion by January 21, 2026. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a major pharmaceutical distributor and healthcare solutions provider. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. As a prime vendor under this comprehensive global pharmaceutical support vehicle, AmerisourceBergen supplies a broad range of brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs and the Defense Health Agency. The Ibrance procurement exemplifies the company's role in delivering specialty pharmaceutical products to federal medical supply chains, with this particular order supporting oncology treatment needs across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.6k | 12/28/25 |